Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice
Open Access
- 9 September 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 17 (24) , 3864-3875
- https://doi.org/10.1093/hmg/ddn286
Abstract
In order to identify new genes with differential expression in early intestinal tumours, we performed mRNA (messenger ribonucleic acid) expression profiling of 16 human and 63 mouse adenomas. All individuals had germline APC mutations to ensure that tumorigenesis was driven by ‘second hits’ at APC. Using stringent filtering to identify changes consistent between humans and mice, we identified 60 genes up-regulated and 151 down-regulated in tumours. For 22 selected genes—including known Wnt targets—expression differences were confirmed by qRT–PCR (quantitative reverse transcription polymerase chain reaction). Most, but not all, differences were also present in colorectal carcinomas. In situ analysis showed a complex picture. Expression of up-regulated genes in adenomas was usually uniform/diffuse (e.g. ITGA6) or prominent in the tumour core (e.g. LGR5); in normal tissue, these genes were expressed at crypt bases or the transit amplifying zone. Down-regulated genes were often undetectable in adenomas, but in normal tissue were expressed in mesenchyme (e.g. GREM1/2) or differentiated cells towards crypt tops (e.g. SGK1). In silico analysis of TCF4-binding motifs showed that some of our genes were probably direct Wnt targets. Previous studies, mostly focused on human tumours, showed partial overlap with our ‘expression signature’, but 37 genes were unique to our study, including TACSTD2, SEMA3F, HOXA9 and IER3 (up-regulated), and TAGLN, GREM1, GREM2, MAB21L2 and RARRES2 (down-regulated). Combined analysis of our and published human data identified additional genes differentially expressed in adenomas, including decreased BMPs (bone morphogenetic proteins) and increased BUB1/BUB1B. Several of the newly identified, differentially expressed genes represent potential diagnostic or therapeutic targets for intestinal tumours.Keywords
This publication has 24 references indexed in Scilit:
- Cross-Species Comparison of Human and Mouse Intestinal Polyps Reveals Conserved Mechanisms in Adenomatous Polyposis Coli (APC)-Driven TumorigenesisThe American Journal of Pathology, 2008
- Genome-Wide Pattern of TCF7L2/TCF4 Chromatin Occupancy in Colorectal Cancer CellsMolecular and Cellular Biology, 2008
- Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer riskNature Genetics, 2007
- Transcriptome Profile of Human Colorectal AdenomasMolecular Cancer Research, 2007
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007
- Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factorsProceedings of the National Academy of Sciences, 2007
- Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancerGenome Biology, 2007
- Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferationProceedings of the National Academy of Sciences, 2006
- Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic β-catenin proteinOncogene, 2005
- Overexpression of Orphan G–Protein-Coupled Receptor, Gpr49 , in Human Hepatocellular Carcinomas With β–Catenin MutationsHepatology, 2003